Financial Analysis

NOTE 5 LOAN PAYABLE On September 15, 2024, the Company entered into a loan agreement with a non-affiliate party at $128,401 to support operating expense of the Company. The loan has a maturity date of September 15, 2026 and interest rate at 8% per annum. On December 3, 2025, the Company entered into a loan settlement agreement through the issuance of 2,140,016 common shares. As of December 31, 2025, 2,140,016 shares remained outstanding and were recorded as stock payable. As of March 31, 2026 and December 31, 2025, the loan payable was $0. On November 25, 2024, Goldfinch Group Holdings Ltd. entered into a loan agreement with a non-affiliate party at $20,533 (CNY145,172) to support legal set-up cost of the Company. The loan has a maturity date of November 25, 2026 and interest rate at 10% per annum. On December 3, 2025, the Company entered into a loan settlement agreement through the issuance of 342,216 common shares. As of December 31, 2025, 342,216 shares remained outstanding and were recorded as stock payable. As of March 31, 2026 and December 31, 2025, the loan payable was $0. On March 31, 2026, the Company entered into a loan agreement with a non-affiliate party at $40,692 to support operating expense of the Company during the three months ended March 31, 2026. The loan has a maturity date of March 31, 2028 and interest rate at 8% per annum. As of March 31, 2026, the loan payable was $40,692. Interest expense for the three months ended March 31, 2026 and 2025 were $0 and …

DebtDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 9 - INCOME TAX The Company provides for income taxes under ASC 740, Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax basis of assets and liabilities and the tax rates in effect when these differences are expected to reverse. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. The loss from operation before income tax of the Company for the three months ended March 31, 2026 and March 31, 2025 were comprised of the following: For the For the three months ended three months ended March 31, March 31, 2026 2025 Tax jurisdiction from: $ $ - Local 181,214 (77,045 ) - Foreign, representing: China 92,578 (501 ) Hong Kong (209,998 ) - Income (Loss) before income taxes $ 63,794 $ (77,546 ) A reconciliation between expected income taxes and the income tax net expense included in the statements of operations for the three months ended March 31, 2026 and 2025 is as follows: For the For the three months ended three months ended March 31, 2026 March 31, 2025 Total Total Net income (loss) before income tax $ (3,253,813 ) $ (486,397 ) Statutory tax Rate 21 % 21 % Tax (benefit) expense at the statutory tax rate (687,998 ) (102,163 ) Tax effect of Stock-based compensation 696,697 85,859 Changes in valuation allowance (8,700 ) 16,304 Income tax expense …

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

In November 2024, the FASB issued ASU 2024-03, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40), which requires enhanced disclosures of certain income statement expenses. In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. The standard is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted, either prospectively or retrospectively. In December 2025, the FASB issued ASU No.2025-11- Interim Reporting (Topic270): Narrow-Scope Improvements which is designed to improve the navigability of interim reporting guidance and clarify its applicability without fundamentally changing the nature of interim reporting. In introduces a principle requiring entities to disclose events or changes since the last annual reporting period that have a material impact on the entity. The new guidance is effective for annual reporting periods beginning December 15, 2027. Early adoption is permitted. We are currently evaluating the impact this update will have on our consolidated financial statements and disclosures. We have evaluated all other recently issued, but not yet effective, accounting pronouncements and do not believe that these accounting pronouncements will have any material impact on our consolidated financial statements or disclosures upon adoption. …

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

NOTE 6 RELATED PARTY TRANSACTIONS AND BALANCES 1) Nature of relationships with related parties The table below sets forth the major related parties and their relationships with the Company, with which the Company entered into transactions for the three months ended March 31, 2026 and 2025 and recorded balances as of March 31, 2026 and December 31, 2025, respectively. Name of Related Party Relationship to the Company Mengqing Fan Director of Transuite.Org. Inc. Xiaohuan Song Director of Goldfinch Group Holdings Ltd. and Goldfinch Group Co., Ltd. (Hong Kong) Hailiang Li Director of Xirangsheng (Shenzhen) Health Technology Co., Ltd. and Solan (Shenzhen) Technology Co., Ltd. Zeng Lianghui Director of Goldfinch-Chong (Fuzhou) Technology Co., Ltd. Qianglong Zeng Former Director of Transuite.Org. Inc. resigned on February 12, 2026 2) Balances with related parties As of As of March 31, 2026 December 31, 2025 Amount due from related party Non-trade Amount due from Mengqing Fan $ 19,801 $ 8,901 $ 19,801 $ 8,901 Amount due to related parties Non-trade Amount due to Xiaohuan Song $ 1,786 $ 1,785 Amount due to Zeng Lianghui 1,450 1,430 Amount due to Hailiang Li 12,102 8,467 $ 15,338 $ 11,682 3) Transactions with related parties For the For the three months ended three months ended March 31, 2026 March 31, 2025 Advancement from Mengqing Fan for Transuite.Org. Inc. operation expenses $ - $ 9,606 Repayment to Mengqing Fan for her advancement to Transuite Org. $ (10,900 ) $ - Advancement from …

RelatedPartyTransactionsDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 10 SEGMENT REPORTING Operating segments are components of an entity for which separate financial information is available and evaluated by the Companys chief operating decision maker (CODM) in determining how to allocate resources and assess performance. As of March 31, 2026, the Company operates through the following reporting segments: Technology and consulting services conducted through Transuite.Org Inc.; Online medical education services conducted through Solan (Shenzhen) Technology Co., Ltd., which was acquired on September 29, 2025; and Intelligent infrastructure and e-bike charging management solutions conducted through Goldfinch-Chong (Fuzhou) Technology Co., Ltd. The Companys chief operating decision makers (CODM) are the Chief Executive Officers and Directors of the respective entities. Since September 2024, the Company has undertaken strategic restructuring efforts, including reorganization of management functions and expansion into technology-driven service offerings. During the three months ended March 31, 2026, the Companys primary operating activities consisted of strategic consulting and technology-related services, including business solution development and digital platform-related deliverables. For the three months ended March 31, 2026 and 2025, the Company reported revenue of $121,784 and $0, respectively. The revenue was primarily derived from e-biking charging solution and on-line medical education. The online medical education segment commenced op …

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing

"NOTE 3 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying audited consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (""GAAP"") and are presented in US dollars. The Company uses the accrual basis of accounting and has a December 31 fiscal year end. Basis of Consolidation These consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries of Goldfinch Group Holdings Ltd. (including its wholly owned subsidiary Crestar Holding Ltd.), Solan (Shenzhen) Technology Co., Ltd., Xirangsheng (Shenzhen) Health Technology Co., Ltd., 80% owned Jiansheng (Shenzhen) Technology Co., Ltd. and 51% owned SolanAI Global Ltd. (including its wholly owned subsidiary Yuan Qi (Shenzhen) AI Co., Ltd. and Goldfinch Group Co., Ltd. (including its wholly subsidiary Goldfinch-Chong (Fuzhou) Technology Co., Ltd.. All material intercompany balances and transactions have been eliminated. Functional Acquisition Entity % owned Currency Date Transuite. Org. Inc. Parent USD Goldfinch Group Holdings Ltd. (BVI) (Note 1) Subsidiary 100 % CNY 11/24/2024 Crestar Holdings Ltd. (Hong Kong) Subsidiary 100 % HKD 8/14/2025 Jiansheng (Shenzhen) Technology Co., Ltd. Subsidiary 80 % CNY 9/16/2025 Solan (Shenzhen) Technology Co., Ltd. Subsidiary 100 % CNY 9/29/2025 Xirangsheng (Shenzhen) Health Technology Co., Ltd. Subsidiary 100 % CNY 9/30/2025 Gold …

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

NOTE 7 - EQUITY Preferred Shares On April 14, 2026, the Company filed Amended and Restated Articles of Incorporation establishing 100,000,000 shares of preferred stock, par value $0.001 per share in one or more series. Common Shares Three Months Ended March 31, 2026 On April 14, 2026, the Company filed Amended and Restated Articles of Incorporation increasing the number of authorized common shares from 75,000,000, to 1,000,000,000 $0.001 par value shares of common stock. On January 2, 2026, the Company issued 2,140,016 common shares for the settlement of loan payable of $128,401 in pursuant to the settlement agreement entered on December 3, 2025. (Note 5) On January 16, 2026, the Company issued 666,666 common shares for the settlement of a trade payable of $40,000 in pursuant to the settlement agreement entered on December 3, 2025. (Note 5) On March 31 2026, the Company issued 342,216 common shares for the settlement of loan payable of $20,533 in pursuant to the settlement agreement entered on December 3, 2025. (Note 5) From January to February 2026, 3,500,000 common shares were issued as partial consideration for the acquisition of 51% equity interest in Goldfinch Group Co. Ltd. (Hong Kong) in pursuant to share exchange agreement entered on December 31, 2025. The remaining consideration of 1,500,000 common shares will be issued within year 2026. Pursuant to a cooperation agreement entered with Honwo Technology Holding Limited (Honwo) to establish a strategic collaboration fr …

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

NOTE 11 SUBSEQUENT EVENTS In accordance with ASC 855, Subsequent Events, the Company has analyzed its operations subsequent to March 31, 2026 to the date these financial statements were issued and has determined that it has the below material subsequent event to disclose in these financial statements. Authorized Share Increase On March 10, 2026, the Company filed a Definitive Information Statement on Schedule 14C with the Securities and Exchange Commission relating to the approval of an Amended and Restated Articles of Incorporation to increase the number of authorized shares of common stock. The amendment is expected to become effective upon filing with the Nevada Secretary of State following expiration of the applicable notice period. The Company is currently completing the related corporate filings. On April 14, 2026, the Company filed Amended and Restated Articles of Incorporation with the Nevada Secretary of State, and the Amended and Restated Articles became effective upon filing. Among other things, the Amended and Restated Articles amended and restated the Companys articles of incorporation to provide that the total number of shares of capital stock that the Company is authorized to issue is 1,100,000,000 shares, consisting of (i) 1,000,000,000 shares of common stock, par value $0.001 per share, and (ii) 100,000,000 shares of preferred stock, par value $0.001 per share. The Amended and Restated Articles also include provisions relating to the authorization of preferre …

SubsequentEventsTextBlock · excerpt; the full note is in the filing